Newsroom

Share:

EmailFacebookLinkedInXWhatsAppShare
Publication date (field_publication_date)
NIBIB in the News · October 12, 2021

SARS-CoV-2, the virus that causes COVID-19, doesn’t always cause symptoms, but people who have asymptomatic infections can unknowingly spread the disease. These asymptomatic infections may cause up to half of the viral spread in the United States. Source: NIH.gov

NIBIB in the News · October 1, 2021

National Institutes of Health Common Fund’s Bridge2AI Program Will Build Ethical, Inclusive, and Interpretable Data Sets.

NIBIB in the News · October 1, 2021

National Institutes of Health Common Fund’s Bridge2AI Program Will Build Ethical, Inclusive, and Interpretable Data Sets.

NIBIB in the News · September 29, 2021

In this year's edition of the Minnies, AuntMinnie.com recognizes excellence in radiology. Dr. Judy Gichoya, 2021 DATA Scholar at NIBIB and Fogarty International Institute, and an Emory University assistant professor is one of the finalists for Most Influential Radiology Researcher. Source AuntMinnie.com.

Grantee News · September 28, 2021

ANP Technologies announced on Monday that its SARS-CoV-2 rapid antigen test has received Emergency Use Authorization from the US Food and Drug Administration.

Grantee News · September 28, 2021

With the Covid-19 pandemic causing ventilator shortages around the globe, three biomedical engineering graduates from the University of South Florida are receiving national recognition for their efforts to mitigate the scarcity of these lifesaving machines.

NIBIB in the News · September 22, 2021

Duke Engineering’s First-Year Design program team triumphed at the NIH’s 9th annual DEBUT Challenge. The team’s project, named LowCostomy, received the National Cancer Institute Prize for Technologies for Cancer Prevention, Diagnosis and Treatment. The team received $15,000 in prize money in recognition for their work. Source: Duke University.

Science Highlights · September 22, 2021

NIBIB-funded engineers are using focused ultrasound to modulate motor activity in the brain without surgical device implantation, a first step toward non-invasive brain stimulation therapies.

Grantee News · September 21, 2021

A new $13.3 million contract from the NIH's Rapid Acceleration of Diagnostics (RADx) initiative will enable the David Geffen School of Medicine at UCLA to expand its capacity to process COVID-19 tests.